Your fact-checks will appear here
Family name
No credible 2024–2025 clinical trial announced a universal “cure” for dementia; instead, the period saw multiple trials showing modest disease‑slowing effects, new drug approvals for early Alzheimer’s...
Caregivers seeking reputable guidance on alternative (non‑drug) Alzheimer’s therapies in 2025 should prioritize major clinical guidance bodies and peer‑reviewed reviews: the Alzheimer’s Association an...
Alzheimer’s treatment reporting mixes robust clinical trials (182 trials of 138 drugs on Jan 1, 2025) with early-stage lab and animal work; disease‑modifying anti‑amyloid antibodies such as lecanemab ...
Available sources show extensive preclinical interest in honey and bee products for Alzheimer’s disease (AD) but they do not document any registered human clinical trials testing honey or honey-derive...
Available reporting in the provided results does not show any peer‑reviewed or regulator‑facing phase trial readouts for a prescription drug named “Neurocept”; instead, the material is marketing, revi...